Target Name: LOC105379658
NCBI ID: G105379658
Review Report on LOC105379658 Target / Biomarker Content of Review Report on LOC105379658 Target / Biomarker
LOC105379658
Other Name(s): DLA class II histocompatibility antigen, DR-1 beta chain-like

A Potential Drug Target: LOC105379658 (DLA class II histocompatibility antigen, DR-1 beta chain-like)

LOC105379658 (DLA class II histocompatibility antigen, DR-1 beta chain-like) is a protein that is expressed in a variety of tissues, including the skin, hair, and nails, and is involved in the immune response. Its function and regulation have been studied extensively, and its potential as a drug target have been identified. In this article, we will explore the biology of LOC105379658 and its potential as a drug target.

The Role of LOC105379658 in the Immune Response

LOC105379658 is a member of the major histocompatibility complex (MHC) class II molecules. MHC molecules are responsible for presenting antigens from the body's immune system to T-cells, which then differentiate into memory T-cells that recognize and respond to the presented antigens.

LOC105379658 is expressed in a variety of tissues and is involved in the immune response by regulating the activation and proliferation of immune cells. Specifically, LOC105379658 has been shown to regulate the development and function of natural killer cells, which are a crucial part of the immune system's response to cancer.

In addition to regulating natural killer cells, LOC105379658 has also been shown to play a role in regulating the activation and proliferation of T-cells. Specifically, LOC105379658 has been shown to promote the development and expansion of CD4+ T-cells, which are a critical part of the immune system's response to infections and other threats.

The Potential Role of LOC105379658 as a Drug Target

The potential use of LOC105379658 as a drug target is based on its involvement in the immune response and its regulation of immune cell function. Several studies have identified potential drug targets in the MHC class II molecules, including LOC105379658.

One potential drug target for LOC105379658 is the use of small molecules that can modulate its activity. For example, several studies have shown that small molecules can inhibit the activity of LOC105379658 and enhance its presentation of antigens to T-cells. These small molecules have the potential to be used as anti-inflammatory agents or to enhance the immune response.

Another potential drug target for LOC105379658 is the use of antibodies that can specifically recognize and target its activity. For example, several studies have shown that antibodies can be used to recognize and block the activity of LOC105379658 and enhance the immune response. These antibodies have the potential to be used as a diagnostic tool or as a therapeutic agent.

Conclusion

LOC105379658 is a protein that is involved in the immune response and its regulation. Its potential as a drug target has been identified based on its involvement in the immune response and its regulation of immune cell function. Further studies are needed to fully understand the biology of LOC105379658 and its potential as a drug target.

Protein Name: DLA Class II Histocompatibility Antigen, DR-1 Beta Chain-like

The "LOC105379658 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379658 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225